EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Vaginal Microbiota and Ovarian Cancer: A New Frontier in Immunomodulation and Diagnosis

Wafa Babay iD, Mariem Garci, Ahmed Baligh Laaribi, Nabil Mathlouthi, Imene Ouzari iD

Immunology · 2026

DOI: 10.1111/imm.70112 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology, 2026. Verfasst von Wafa Babay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microorganisms and Bioactive Molecules, Faculty of Sciences, University of Tunis El Manar, Tunis, Tunisia. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Vagina, Microbiota, Immunomodulation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Tunisian National Universitaire de Documentation Scientifique et Technique (CNUDST), University of Tunis El Manar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer remains one of the deadliest gynaecological cancers due to its often‐late diagnosis and the absence of specific symptoms in the early stages. Beyond genetic alterations, the tumour microenvironment, including the vaginal microbiota, plays a decisive role in tumour progression. Recent studies have highlighted the involvement of microbial imbalance ‘dysbiosis’ in ovarian carcinogenesis, particularly through interactions with the immune system and the modulation of local inflammatory pathways such as Th17‐related pathways. In a state of ‘eubiosis,’ the vaginal microbiota, dominated by Lactobacillus species, plays a protective role by producing lactic acid, maintaining an acidic pH, and preventing infections. Conversely, dysbiosis, characterised by a decrease in lactobacilli and an increase in opportunistic bacteria such as Gardnerella , Atopobium and Prevotella, promotes chronic inflammation through Toll‐like receptor signalling, stimulates the production of IL‐6, IL‐8 and TNF‐α, thereby creating a pro‐tumour immune microenvironment conducive to tumour development. The complex interactions of the microbial flora, mucosal immunity, and tumour cells could explain the association between vaginal microbiota and ovarian cancer. This review highlights these mechanisms and emphasises the potential of vaginal microbiota as a tool for early detection and improved diagnosis of ovarian cancer. A better understanding of this microbe‐host dialogue could pave the way for new prevention and detection strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsVaginaMicrobiotaImmunomodulationHumansFemaleTumor MicroenvironmentAnimalsDysbiosis

Stichwörter der Autor:innen

dysbiosisearly detectionimmune modulationovarian cancervaginal microbiota

Autor:innen und Institutionen

  • Laboratory of Microorganisms and Bioactive Molecules, Faculty of Sciences, University of Tunis El Manar, Tunis, Tunisia.
  • Department A of Gynecology and Obstetrics, Charles Nicolle University Hospital of Tunis, Tunis, Tunisia.
  • Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.

ORCID-Profile: Wafa Babay, Imene Ouzari

Förderung

  • Tunisian National Universitaire de Documentation Scientifique et Technique (CNUDST), University of Tunis El Manar

Zitieren

APA

Babay, W., Garci, M., Laaribi, A. B., Mathlouthi, N., & Ouzari, I. (2026). Vaginal Microbiota and Ovarian Cancer: A New Frontier in Immunomodulation and Diagnosis. Immunology. https://doi.org/10.1111/imm.70112

Vancouver

Babay W, Garci M, Laaribi AB, Mathlouthi N, Ouzari I. Vaginal Microbiota and Ovarian Cancer: A New Frontier in Immunomodulation and Diagnosis. Immunology. 2026. doi:10.1111/imm.70112

BibTeX
@article{Babay2026,
  author = {Babay, Wafa and Garci, Mariem and Laaribi, Ahmed Baligh and Mathlouthi, Nabil and Ouzari, Imene},
  title = {Vaginal Microbiota and Ovarian Cancer: A New Frontier in Immunomodulation and Diagnosis},
  journal = {Immunology},
  year = {2026},
  doi = {10.1111/imm.70112}
}
Kostenlos starten →